Literature DB >> 3976845

Changes in the macrophage content of lung metastases at different stages in tumor growth.

P J Bugelski, R L Kirsh, J M Sowinski, G Poste.   

Abstract

The macrophage content of experimental B16 melanoma metastases at different stages of their growth has been quantified with the use of morphometry in conjunction with a recently developed histochemical method for selectively staining intratumoral macrophages. Data are presented from analyses of 954 sections of 155 individual lung metastases, showing that the macrophage content of individual B16 melanoma lung metastases not only varies significantly but also falls dramatically once metastases contain more than 700 tumor cells. In addition to providing new information on host response reactions of micrometastases, these experiments also indicate that conclusions on intratumoral macrophages derived from studies of large primary tumors and metastases in advanced stages of growth may have little or no relevance to events in micrometastases.

Entities:  

Mesh:

Year:  1985        PMID: 3976845      PMCID: PMC1887940     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  17 in total

1.  Detection and quantitation of macrophage infiltration into primary human tumors with the use of cell-surface markers.

Authors:  G W Wood; K A Gollahon
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

2.  New histochemical method for measuring intratumoral macrophages and macrophage recruitment into experimental metastases.

Authors:  P J Bugelski; R L Kirsh; G Poste
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

3.  Concurrent depression of tumor macrophage infiltration and systemic inflammation by progressive cancer growth.

Authors:  S J Normann; J Cornelius
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

4.  The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

Authors:  E R Fisher; R M Gregorio; B Fisher; C Redmond; F Vellios; S C Sommers
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

5.  Identification and characterization of a monoclonal antibody to an antigen expressed on activated macrophages.

Authors:  T P Koestler; D Rieman; K Muirhead; R G Greig; G Poste
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  FPi analysis. II. Use of the method to monitor the in vivo kinetics of cell populations perturbed by hydroxyurea.

Authors:  S Zietz; S Lessin; M Grattarola; C Desaive; C Nicolini
Journal:  Cell Tissue Kinet       Date:  1980-09

7.  The effects of tumor facilitating factor of B16 melanoma on the macrophage.

Authors:  R Kalish; N I Brody
Journal:  J Invest Dermatol       Date:  1983-03       Impact factor: 8.551

Review 8.  Macrophages and neoplasms: new insights and their implication in tumor immunobiology.

Authors:  R Evans
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

9.  Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.

Authors:  G Poste; R Kirsh; W E Fogler; I J Fidler
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

10.  Macrophage content of metastatic and nonmetastatic rodent neoplasms.

Authors:  J E Talmadge; M Key; I J Fidler
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

View more
  12 in total

1.  Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer.

Authors:  Neveen Said; Steven Smith; Marta Sanchez-Carbayo; Dan Theodorescu
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

Review 2.  Macrophage infiltration and tumor progression.

Authors:  S J Normann
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

3.  Enhancement of nitric oxide release in mouse inflammatory macrophages co-cultivated with tumor cells of a different origin.

Authors:  Lido Calorini; Francesca Bianchini; Antonella Mannini; Gabriele Mugnai; Salvatore Ruggieri
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 4.  Therapy of disseminated melanoma by liposome-activated macrophages.

Authors:  I J Fidler
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

5.  Antimetastatic pectic polysaccharide from Decalepis hamiltonii; galectin-3 inhibition and immune-modulation.

Authors:  Sathisha U Venkateshaiah; Mallikarjuna S Eswaraiah; Harish Nayaka M Annaiah; Shylaja M Dharmesh
Journal:  Clin Exp Metastasis       Date:  2017-02-03       Impact factor: 5.150

Review 6.  Tumour-associated macrophages and melanoma tumourigenesis: integrating the complexity.

Authors:  Mahmoud R Hussein
Journal:  Int J Exp Pathol       Date:  2006-06       Impact factor: 1.925

7.  Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases.

Authors:  Tomonori Tanei; Fransisca Leonard; Xuewu Liu; Jenolyn F Alexander; Yuki Saito; Mauro Ferrari; Biana Godin; Kenji Yokoi
Journal:  Cancer Res       Date:  2016-01-07       Impact factor: 12.701

Review 8.  Kupffer cells and liver metastasis. Optimization and limitation of activation of tumoricidal activity.

Authors:  N C Phillips
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

9.  Recruitment of exogenous macrophages into metastases at different stages of tumor growth.

Authors:  P J Bugelski; R Kirsh; C Buscarino; S P Corwin; G Poste
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

10.  Different patterns of macrophage infiltration into allogeneic-murine and xenogeneic-human neoplasms growing in nude mice.

Authors:  C D Bucana; A Fabra; R Sanchez; I J Fidler
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.